CompanyOverview|NYSE:NVO] Despite a double beat in its quarterly earnings on May 7, Novo Nordisk A/S (NYSE: NVO) stock is ...

CVS Health's stock price received a positive prognosis from Truist Financial, boosting the target from $82 to $84. The ...

CVS Health CVS shares have rallied nearly 38% so far this month, driven by the company’s stronger-than-expected first-quarter ...

Bernie Sanders wonders if Trump is "serious about making real change rather than just issuing a press release." ...

The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.

The blow came from the highest levels of government, spooking investors and driving down the stock prices of numerous ...

A measure now on the floor of the Nebraska Legislature would address some practices by intermediaries called pharmacy benefit managers that pharmacists say are harming their businesses.

In his Truth Social post on Sunday, Trump claimed his order would "almost immediately" reduce prescription drug and pharmaceutical prices by 30% to 80%. On average, Americans pay about three times ...

Shares of Alphamab Oncology plunged 14.4% to HK$6.28, leading declines in Hong Kong-listed pharmaceutical stocks.Meanwhile, ...

Shares of CVS Health Corp. CVS soared toward a one-year high in early Thursday trading, after the healthcare-services company dropped a bombshell on investors — it’s leaving the Obamacare ...

Investors are worried Novo Nordisk's competition with Eli Lilly is heating up and that the first-to-market GLP-1 leader is ...

Novo reported $11.9 billion in revenues, in line with Wall Street's estimates, and beat on adjusted earnings per share (EPS) ...